Past Event

Conference on Clinical Cancer Research

The 2009 Conference on Clinical Cancer Research, hosted by the Engelberg Center for Health Care Reform and Friends of Cancer Research, brought together distinguished members of the cancer community for in-depth discussions of critical issues at the intersection of clinical research and policy.

The all-day event on September 14 convened leaders from the National Cancer Institute (NCI), academia, patient advocacy organizations, the Food and Drug Administration (FDA), and various industry organizations, to discuss specific research and policy issues, as well as build consensus around solutions to critical questions regarding the future of clinical cancer research.

Opening remarks were delivered by NCI Director John Niederhuber, with keynote remarks offered by FDA Commissioner Margaret Hamburg. Interactive panel discussions focused on optimal data collection for clinical trials, development and approval of targeted therapies, and development of combination therapies targeting multiple pathways.



Panel 1: Data Submission Standards and Evidence Requirements


Robert Temple

Deputy Director for Clinical Science, Center for Drug Evaluation and Research - U.S. Food and Drug Administration

Panel 2: Blinded Independent Central Review of PFS Endpoints


Lori Dodd

National Institute of Allergy and Infectious Diseases

Keynote Address

Panel 3: Accelerating Development and Approval of Targeted Cancer Therapies

Panel 4: Development of Two Novel Therapeutics Targeting Multiple Pathways


Adam Clark

Director, Scientific and Federal Affairs, Faster Cures


Janet Woodcock

Director, Center for Drug Evaluation and Research - US Food and Drug Administration

Summary and Closing Remarks

More Information

Get a weekly events calendar from Brookings